NTRB
Nutriband Inc
NASDAQ: NTRB · HEALTHCARE · BIOTECHNOLOGY
$3.87
+1.98% today
Updated 2026-04-30
Market cap
$45.78M
P/E ratio
—
P/S ratio
20.09x
EPS (TTM)
$-3.05
Dividend yield
—
52W range
$3 – $12
Volume
0.0M
Nutriband Inc (NTRB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-147923.00 | $-147923.00 | $-92858.00 | $-1.11M | $-894470.00 | $-297055.00 | $-2.81M | $-2.99M | $-3.53M | $-4.63M | $-5.13M |
| Capital expenditures | $4163.00 | $4163.00 | $4163.00 | $4163.00 | $81595.00 | $81595.00 | $81595.00 | $79304.00 | $51761.00 | $92043.00 | $5324.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $7770.00 | — | $1.76M | $252700.00 | $2.00M | $1.36M | $732130.00 | $742696.00 | $1.54M | $104400.00 |
| Free cash flow | $-152086.00 | $-152086.00 | $-97021.00 | $-1.11M | $-976065.00 | $-378650.00 | $-2.89M | $-3.07M | $-3.58M | $-4.72M | $-5.14M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $0.00 | $0.00 | $2.50M | $0.00 | — | — | $196589.00 | $296875.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $141812.00 | — | — | — | — | — |